Gaetano Riemma

Dr. Gaetano Riemma

Department of Woman, Child, and General and Specialized Surgery, University of Campania "Luigi Vanvitelli”, Naples, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PGPierluigi Giampaolino
Pierluigi Giampaolino
VFVirginia Foreste
Virginia Foreste
CFClaudia Di Filippo
Claudia Di Filippo
AGAlessandra Gallo
Alessandra Gallo
Antonio MercorioAntonio Mercorio
Antonio Mercorio
Luigi Della CorteLuigi Della Corte
Luigi Della Corte
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease. The hypothesis that alterations in the microbiome are involved in the genesis of PCOS has been postulated. Aim of this review is to summarize the available literature data about the relationship between microbiome and PCOS. A search on PubMed and Medline databases was performed from inception to November 20Most of evidence has focused on the connection of intestinal bacteria with sex hormones and insulin-resistance: while in the first case, a relationship with hyperandrogenism has been described, although it is still unclear, in the second one, chronic low-grade inflammation by activating the immune system, with increased production of proinflammatory cytokines which interfere with insulin receptor function, causing IR (Insulin Resistance)/hyperinsulinemia has been described, as well as the role of gastrointestinal hormones like Ghrelin and peptide YY (PYY), bile acids, interleukin-22 and Bacteroides vulgatus have been highlighted. The lower genital tract microbiome would be affected by changes in PCOS patients too. The therapeutic opportunities include probiotic, prebiotics and synbiotics, as well as fecal microbiota transplantation and the use of IL-22, to date only in animal models, as a possible future drug. Current evidence has shown the involvement of the gut microbiome in PCOS, seen how humanized mice receiving a fecal transplant from women with PCOS develop ovarian dysfunction, immune changes and insulin resistance and how it is capable of disrupting the secondary bile acid biosynthesis. A future therapeutic approach for PCOS may involve the human administration of IL-22 and bile acid glycodeoxycholic acid.

1 April 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
GRGaetano Riemma
Gaetano Riemma
Jose CarugnoJose Carugno
Jose Carugno
TMTirso Pérez Medina
Tirso Pérez Medina
LPLuis Alonso Pacheco
Luis Alonso Pacheco
PFPasquale De Franciscis
Pasquale De Franciscis

Verified
Journal Article
Open access
PDF file
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
FFFederico Ferrari
Federico Ferrari
MCMichal Ciebiera
Michal Ciebiera
MZMagdalena Zgliczyńska
Magdalena Zgliczyńska
ARAgnese Maria Chiara Rapisarda
Agnese Maria Chiara Rapisarda
SCStefano Cianci
Stefano Cianci
The human microbiome plays a crucial role in determining the health status of every human being, and the microbiome of the genital tract can affect the fertility potential before and during assisted reproductive treatments (ARTs). This review aims to identify and appraise studies investigating the correlation of genital microbiome to infertility. Publications up to February 2021 were identified by searching the electronic databases PubMed/MEDLINE, Scopus and Embase and bibliographies. Only full-text original research articles written in English were considered eligible for analysis, whereas reviews, editorials, opinions or letters, case studies, conference papers, and abstracts were excluded. Twenty-six articles were identified. The oldest studies adopted the exclusive culture-based technique, while in recent years PCR and RNA sequencing based on 16S rRNA were the most used technique. Regardless of the anatomical site under investigation, the Lactobacillus-dominated flora seems to play a pivotal role in determining fertility, and in particular Lactobacillus crispatus showed a central role. Nonetheless, the presence of pathogens in the genital tract, such as Chlamydia trachomatis, Gardnerella vaginalis, Ureaplasma species, and Gram-negative stains microorganism, affected fertility also in case of asymptomatic bacterial vaginosis (BV). We failed to identify descriptive or comparative studies regarding tubal microbiome. The microbiome of the genital tract plays a pivotal role in fertility, also in case of ARTs. The standardization of the sampling methods and investigations approaches is warranted to stratify the fertility potential and its subsequent treatment. Prospective tubal microbiome studies are warranted.

4 August 2022 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
GRGaetano Riemma
Gaetano Riemma
SHSergio Haimovich
Sergio Haimovich
JCJose Carugno
Jose Carugno
LPLuis Alonso Pacheco
Luis Alonso Pacheco
PFPasquale De Franciscis
Pasquale De Franciscis

28 August 2019 in Medicina
Verified
Journal Article
Open access
PDF file
PFPasquale De Franciscis
Pasquale De Franciscis
NCNicola Colacurci
Nicola Colacurci
GRGaetano Riemma
Gaetano Riemma
ACAnna Conte
Anna Conte
EPErika Pittana
Erika Pittana
Antonio SchiattarellaAntonio Schiattarella
Antonio Schiattarella
The menopausal transition, or perimenopause, is characterized by menstrual irregularities, vasomotor symptoms, sleep disturbances, mood symptoms, and urogenital tract atrophy. These changes can also affect the quality of life and one’s self-esteem. Hormone replacement therapy (HRT) is considered the best option to achieve therapeutic relief of different menopausal symptoms but is usually restricted to moderate or severe symptoms. Moreover, many women refuse HRT for a variety of reasons concerning the fear of cancer and other adverse effects. According to these considerations, new topics are emerging: Dissatisfaction with drug costs and conventional healthcare, desire for personalized medicines, and the public perception that “natural is good”. In this context, nonhormonal therapies are mostly evolving, and it is not unusual that women often request a “natural” approach for their symptoms. The aim of this study is to investigate nonhormonal therapies that have been identified to reduce the menopausal symptoms.

13 April 2023 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Open access
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
GBGiovanni Buzzaccarini
Giovanni Buzzaccarini
GRGaetano Riemma
Gaetano Riemma
LPLuis Alonso Pacheco
Luis Alonso Pacheco
ASAttilio Di Spiezio Sardo
Attilio Di Spiezio Sardo
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
This practice guideline provides updated evidence for the gynecologist who performs endometrial biopsy (EB) in gynecologic clinical practice. An international committee of gynecology experts developed the recommendations according to AGREE Reporting Guideline. An adequate tissue sampling is mandatory when performing an EB. Blind methods should not be first choice in patients with suspected endometrial malignancy. Hysteroscopy is the targeted-biopsy method with highest diagnostic accuracy and cost-effectiveness. Blind suction techniques are not reliable for the diagnosis of endometrial polyps. In low resources settings, and in absence of the capacity to perform office hysteroscopy, blind techniques could be used for EB. Hysteroscopic punch biopsy allows to collect only limited amount of endometrial tissue. grasp biopsy technique should be considered first choice in reproductive aged women, bipolar electrode chip biopsy should be preferred with hypotrophic or atrophic endometrium. EB is required for the final diagnosis of chronic endometritis. There is no consensus regarding which endometrial thickness cut-off should be used for recommending EB in asymptomatic postmenopausal women. EB should be offered to young women with abnormal uterine bleeding and risk factors for endometrial carcinoma. Endometrial pathology should be excluded with EB in nonobese women with unopposed hyperestrogenism. Hysteroscopy with EB is useful in patients with abnormal bleeding even without sonographic evidence of pathology. EB has high sensitivity for detecting intrauterine pathologies. In postmenopausal women with uterine bleeding, EB is recommended. Women with sonographic endometrial thickness > 4 mm using tamoxifen should undergo hysteroscopic EB.